What is difference between bioequivalence and bioavailability?
What is difference between bioequivalence and bioavailability?
Bioavailability is a measurement of the rate and extent to which a therapeutically active chemical is absorbed from a drug product into the systemic circulation and becomes available at the site of action. If two drugs are bioequivalent, there is no clinically significant difference in their bioavailability.
What factors affect bioequivalence?
Factors which influence bioavailability
- Drug concentration at site of administration.
- Surface area of the absorptive site.
- Drug pKa.
- Drug molecule size.
- pH of the surrounding fluid.
What are the 2 types of bioavailability?
Relative bioavailability and bioequivalence When the standard consists of intravenously administered drug, this is known as absolute bioavailability (see above). Relative bioavailability is one of the measures used to assess bioequivalence (BE) between two drug products.
What is the meaning of bioequivalence?
Bioequivalence is defined as ‘the absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an …
What is Cmax and AUC?
Abstract. In bioequivalence studies, the maximum concentration (Cmax) is shown to reflect not only the rate but also the extent of absorption. Cmax is highly correlated with the area under the curve (AUC) contrasting blood concentration with time.
What is bioavailability in Biopharmaceutics?
Bioavailability Bioavailability is a measurement of the rate and extent (amount) to which the active ingredient or active moiety becomes available at the site of action. Bioavailability is also considered as a measure of the rate and extent of therapeutically active drug that is systemically absorbed.
What are three 3 factors that alter bioavailability?
Polymorphism. Many drugs (e.g. carbamazepine) and excipients (e.g. lactose) exhibit polymorphism. Polymorphs have different solubilities.
What factors reduce bioavailability?
Drug bioavailability after oral administration is affected by anumber of different factors, including physicochemical properties of the drug, physiological aspects, the type of dosage form, food intake, biorhythms, and intra- and interindividual variability of the human population.
Which form of drug has highest bioavailability?
Which form of the drug has the highest bioavailability? Explanation: Solutions are readily available. Thus having the highest bioavailability.
What does poor oral bioavailability mean?
Oral bioavailability (F%) is the fraction of an oral administered drug that reaches systemic circulation. A poor oral bioavailability can result in low efficacy and higher inter-individual variability and therefore can lead to unpredictable response to a drug.
Why bioequivalence is important?
Bioequivalence studies are very important for the development of a pharmaceutical preparation in the pharmaceutical industry. Their rationale is the monitoring of pharmacokinetic and pharmacodynamic parameters after the administration of tested drugs.
What does AUC stand for?
Area Under the Curve
The Area Under the Curve (AUC) is the measure of the ability of a classifier to distinguish between classes and is used as a summary of the ROC curve. The higher the AUC, the better the performance of the model at distinguishing between the positive and negative classes.
How are bioavailability and bioequivalence used in drug trials?
One may be comparing two tablets, or a tablet to a suppository, or something similar. Welsh (2011) produces an excellent example of how one might devise a drug trial to test the relative bioavailability of two competing formulations. This has never been asked about in the exam, but could come up in some sort of viva scenario.
Is there a mathematical proof of bioavailability?
For the casually interested user of (at most) primary school-level maths, this mathematical proof is of minimal relevance- it would suffice to agree with Vaughan that it is sound, and to keep using Dost’s law. In summary, bioavailability should really be explained in terms of concentration/time curve AUCs.
How is bioavailability of a drug affected by enzyme activity?
Bioavailability is the fraction of the dose administered that reaches the systemic circulation unchanged. For low hepatic extraction ratio drugs, bioavailability is not affected by enzyme activity, hepatic blood flow or protein binding. Click to see full answer.
What is the acceptable interval of bioequivalence?
The two drugs are then compared in terms of their relative bioavailability. If the AUC ratio of the two drugs is within the range of 0.8-1.25, the drug company can claim that the two formulations are bioequivalent – this is the acceptable interval of bioequivalence ( Rescigno, 1992 ).